HER2 is a member of the epidermal growth factor receptor family that is overexpressed in many human cancers, especially breast cancer, and is related to invasiveness, drug resistance, and poor prognosis.4 Overexpression of HER2 induces proliferation, migration, and invasion of cancer cells through its downstream signaling pathway. Here, ERBB2 is linked to breast cancer.